13045_2017_442_MOESM3_ESM.pdf (1.05 MB)
Download file

Additional file 3 of A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety

Download (1.05 MB)
journal contribution
posted on 23.06.2022, 07:41 authored by Jie Mao, Shujun Liu, Min Ai, Zhuo Wang, Duowei Wang, Xianjing Li, Kaiyong Hu, Xinghua Gao, Yong Yang
Photo of HepG2 tumors of vehicle, blank liposomes (8 mg/kg), melittin (2 mg/kg), melittin nano-liposomes (2, 4, and 8 mg/kg), and sorafenib (30 mg/kg) treated groups in the HepG2 subcutaneous transplanted tumor model. The data are presented as the mean ± SEM. Statistical significance was calculated using Student’s t test (**p ≤ 0.01; ***p ≤ 0.001). (PDF 1070 kb)

Funding

The National Science Foundation of China ‘‘Major Drug Discovery’’ science and technology major projects of China The 111 Project Foundation of Nanjing University of Chinese Medicine

History